Business
Groupe Athena, Inc. Posts Strong 1st Quarter Results Approximating $20,000,000 in Revenues
Groupe Athena, Inc. Posts Strong 1st Quarter Results Approximating $20,000,000 in Revenues.
About this update from Ayujoy Herbals Ltd.
[{"type":"text","content":"\n \n \n Groupe Athena, Inc. Posts Strong 1st Quarter Results Approximating $20,000,000 in Revenues\n \n \nGroupe Athena, Inc. Posts Strong 1st Quarter Results Approximating $20,000,000 in Revenues\n \n MUMBAI, INDIA--(Marketwired - Nov 7, 2017) - Groupe Athena, Inc. (OTC PINK: GATA) today announced revenues of $19,864,908 for the fiscal quarter ending September 30, 2017, representing a 14% growth over the same period in 2016. Operating income before depreciation, amortization and taxes was $3,128,491, an increase of 34.5% over the corresponding period of the previous year. Cash reserves in the form of short term investments and deposits remain strong and the Company has initiated aggressive marketing measures to further revenue growth.\n The Indian pharmaceutical, medical product and device industries is increasingly focusing on exports to the United States and GATA is highly experienced in providing the types of assistance needed to get such products approved by the FDA for sale in the US. All such Indian companies are potential clients of GATA. GATA has a competitive advantage in that it has India-based facilities, and therefore the ability to deliver quick client feedback could result in expedited order generation. GATA recently has been adding equipment to its facilities so that it has increased capacity to meet a growing demand for its services. It believes this combination of factors will result in continued further growth year over year.\n About Groupe Athena, Inc.\n Groupe Athena, Inc. was incorporated in June 2008 and began operations on July 1 of that year. The company is a research and testing organization and helps various pharmaceutical and medical products and devices companies in India and Southeast Asia to get regulatory approvals and facilitate exports of their products to the United States. The Company accomplishes this by assisting clients from concept through development, providing consultation on regulatory requirements, filings and processes.\n The company has a research and marketing facility in India that employs 21 consultants and marketing personnel and is working towards aggressively expanding its presence in the Indian pharmaceutical industry. The Company's web address is www.groupeathena.com.\n To review the complete quarterly report please go to www.otcmarkets.com/stock/GATA/quote and click on...